PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS
The present invention relates to a pharmaceutical composition for preventing or treating diabetes, comprising, as active ingredients: (a) a zinc salt, comprising a zinc cation and anion, and cyclo-hispro, or a pharmaceutically acceptable salt thereof; and (b) an antidiabetic drug (particularly, an i...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SONG MOON KI LEE DO HYUN JEON JONG SU KIM BO BAE JUNG HOE YUNE LEE HEON JONG |
| description | The present invention relates to a pharmaceutical composition for preventing or treating diabetes, comprising, as active ingredients: (a) a zinc salt, comprising a zinc cation and anion, and cyclo-hispro, or a pharmaceutically acceptable salt thereof; and (b) an antidiabetic drug (particularly, an insulin sensitizer, an insulin sensitizer, a sodium-glucose co-transporter (a sodium-glucose co-transporter 2 (SGLT2) inhibitor), or a DPP-4 inhibitor).
本发明涉及含有(a)含锌阳离子与阴离子的锌盐及环二肽-组氨酸脯氨酸，或其药学上可接受的盐；以及(b)作为有效成分的抗糖尿药物(尤其，胰岛素增敏剂(insulin sensitizer)、胰岛素增敏剂(insulin sensitizer)、钠葡萄糖共转运体(Sodium-glucose co-transporter 2(SGLT2)inhibitor)或二肽基肽酶-4抑制剂(DPP-4 inhibitor))的糖尿病预防或治疗用药学组合物。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN111246859A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN111246859A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN111246859A3</originalsourceid><addsrcrecordid>eNqNjcsKwkAMRbtxIeo_xL0u6gtdxjS1gTpTZqKgmyIyrkQL9Tv8ZsfHB7i4JDnkcLvJsyrQbZF4p0JYAtltZb2oWAO5dVA53rNRMRuIlzrGz54JrlnZj6JgFMW84VEMgcdSIz1QaceF-MpZQJPFqHwlIcjcbgPoAUllzxBdx5nEGt9POpfTtQ2D3-wlw5yVinFo7nVom9M53MKjJpOm6WS2WM5XOP3n5wXwIUAX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS</title><source>esp@cenet</source><creator>SONG MOON KI ; LEE DO HYUN ; JEON JONG SU ; KIM BO BAE ; JUNG HOE YUNE ; LEE HEON JONG</creator><creatorcontrib>SONG MOON KI ; LEE DO HYUN ; JEON JONG SU ; KIM BO BAE ; JUNG HOE YUNE ; LEE HEON JONG</creatorcontrib><description>The present invention relates to a pharmaceutical composition for preventing or treating diabetes, comprising, as active ingredients: (a) a zinc salt, comprising a zinc cation and anion, and cyclo-hispro, or a pharmaceutically acceptable salt thereof; and (b) an antidiabetic drug (particularly, an insulin sensitizer, an insulin sensitizer, a sodium-glucose co-transporter (a sodium-glucose co-transporter 2 (SGLT2) inhibitor), or a DPP-4 inhibitor).
本发明涉及含有(a)含锌阳离子与阴离子的锌盐及环二肽-组氨酸脯氨酸，或其药学上可接受的盐；以及(b)作为有效成分的抗糖尿药物(尤其，胰岛素增敏剂(insulin sensitizer)、胰岛素增敏剂(insulin sensitizer)、钠葡萄糖共转运体(Sodium-glucose co-transporter 2(SGLT2)inhibitor)或二肽基肽酶-4抑制剂(DPP-4 inhibitor))的糖尿病预防或治疗用药学组合物。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200605&DB=EPODOC&CC=CN&NR=111246859A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200605&DB=EPODOC&CC=CN&NR=111246859A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SONG MOON KI</creatorcontrib><creatorcontrib>LEE DO HYUN</creatorcontrib><creatorcontrib>JEON JONG SU</creatorcontrib><creatorcontrib>KIM BO BAE</creatorcontrib><creatorcontrib>JUNG HOE YUNE</creatorcontrib><creatorcontrib>LEE HEON JONG</creatorcontrib><title>PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS</title><description>The present invention relates to a pharmaceutical composition for preventing or treating diabetes, comprising, as active ingredients: (a) a zinc salt, comprising a zinc cation and anion, and cyclo-hispro, or a pharmaceutically acceptable salt thereof; and (b) an antidiabetic drug (particularly, an insulin sensitizer, an insulin sensitizer, a sodium-glucose co-transporter (a sodium-glucose co-transporter 2 (SGLT2) inhibitor), or a DPP-4 inhibitor).
本发明涉及含有(a)含锌阳离子与阴离子的锌盐及环二肽-组氨酸脯氨酸，或其药学上可接受的盐；以及(b)作为有效成分的抗糖尿药物(尤其，胰岛素增敏剂(insulin sensitizer)、胰岛素增敏剂(insulin sensitizer)、钠葡萄糖共转运体(Sodium-glucose co-transporter 2(SGLT2)inhibitor)或二肽基肽酶-4抑制剂(DPP-4 inhibitor))的糖尿病预防或治疗用药学组合物。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjcsKwkAMRbtxIeo_xL0u6gtdxjS1gTpTZqKgmyIyrkQL9Tv8ZsfHB7i4JDnkcLvJsyrQbZF4p0JYAtltZb2oWAO5dVA53rNRMRuIlzrGz54JrlnZj6JgFMW84VEMgcdSIz1QaceF-MpZQJPFqHwlIcjcbgPoAUllzxBdx5nEGt9POpfTtQ2D3-wlw5yVinFo7nVom9M53MKjJpOm6WS2WM5XOP3n5wXwIUAX</recordid><startdate>20200605</startdate><enddate>20200605</enddate><creator>SONG MOON KI</creator><creator>LEE DO HYUN</creator><creator>JEON JONG SU</creator><creator>KIM BO BAE</creator><creator>JUNG HOE YUNE</creator><creator>LEE HEON JONG</creator><scope>EVB</scope></search><sort><creationdate>20200605</creationdate><title>PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS</title><author>SONG MOON KI ; LEE DO HYUN ; JEON JONG SU ; KIM BO BAE ; JUNG HOE YUNE ; LEE HEON JONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN111246859A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SONG MOON KI</creatorcontrib><creatorcontrib>LEE DO HYUN</creatorcontrib><creatorcontrib>JEON JONG SU</creatorcontrib><creatorcontrib>KIM BO BAE</creatorcontrib><creatorcontrib>JUNG HOE YUNE</creatorcontrib><creatorcontrib>LEE HEON JONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SONG MOON KI</au><au>LEE DO HYUN</au><au>JEON JONG SU</au><au>KIM BO BAE</au><au>JUNG HOE YUNE</au><au>LEE HEON JONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS</title><date>2020-06-05</date><risdate>2020</risdate><abstract>The present invention relates to a pharmaceutical composition for preventing or treating diabetes, comprising, as active ingredients: (a) a zinc salt, comprising a zinc cation and anion, and cyclo-hispro, or a pharmaceutically acceptable salt thereof; and (b) an antidiabetic drug (particularly, an insulin sensitizer, an insulin sensitizer, a sodium-glucose co-transporter (a sodium-glucose co-transporter 2 (SGLT2) inhibitor), or a DPP-4 inhibitor).
本发明涉及含有(a)含锌阳离子与阴离子的锌盐及环二肽-组氨酸脯氨酸，或其药学上可接受的盐；以及(b)作为有效成分的抗糖尿药物(尤其，胰岛素增敏剂(insulin sensitizer)、胰岛素增敏剂(insulin sensitizer)、钠葡萄糖共转运体(Sodium-glucose co-transporter 2(SGLT2)inhibitor)或二肽基肽酶-4抑制剂(DPP-4 inhibitor))的糖尿病预防或治疗用药学组合物。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN111246859A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A42%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SONG%20MOON%20KI&rft.date=2020-06-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN111246859A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |